Elisa Bergaggio

437 total citations
6 papers, 180 citations indexed

About

Elisa Bergaggio is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Elisa Bergaggio has authored 6 papers receiving a total of 180 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Elisa Bergaggio's work include Lung Cancer Treatments and Mutations (3 papers), CAR-T cell therapy research (2 papers) and Protein Degradation and Inhibitors (2 papers). Elisa Bergaggio is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), CAR-T cell therapy research (2 papers) and Protein Degradation and Inhibitors (2 papers). Elisa Bergaggio collaborates with scholars based in Italy, Switzerland and United States. Elisa Bergaggio's co-authors include Roberto Piva, Elisa Pellegrino, Antonino Neri, Elisabetta Mereu, Francesco Bertoni, Tania Limongi, Wing C. Chan, Stefano Pileri, Luca Agnelli and Alberto Zamò and has published in prestigious journals such as Blood, Cancer Research and Microporous and Mesoporous Materials.

In The Last Decade

Elisa Bergaggio

6 papers receiving 178 citations

Peers

Elisa Bergaggio

MB

PFM

ONCOL

CR

DERMA

Esperanza Martín‐Sánchez Spain

Dejan Radeski Australia

Catalina Amador United States

Xiaohong Zhao China

Tatjana Pandzic Sweden

Martina Tufano Italy

Bipinkumar Amin United States

Francesca Maria Quaglia Italy

Takako Yokomizo‐Nakano Japan

Mu‐Chen Zhang China

Esperanza Martín‐Sánchez Spain

Elisa Bergaggio

118 ×1.4

MB

57 ×0.8

PFM

65 ×1.2

ONCOL

80 ×2.0

CR

9 ×0.3

DERMA

Citations per year, relative to Elisa Bergaggio Elisa Bergaggio (= 1×) peers Esperanza Martín‐Sánchez

Countries citing papers authored by Elisa Bergaggio

Since Specialization

Citations

This map shows the geographic impact of Elisa Bergaggio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Bergaggio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Bergaggio more than expected).

Fields of papers citing papers by Elisa Bergaggio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Bergaggio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Bergaggio. The network helps show where Elisa Bergaggio may publish in the future.

Co-authorship network of co-authors of Elisa Bergaggio

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Bergaggio. A scholar is included among the top collaborators of Elisa Bergaggio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Bergaggio. Elisa Bergaggio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Mecca, Carmen, Ana Paula Azambujá, Elisa Bergaggio, et al.. (2024). Abstract 21: Discovery of ALK-specific TCR clonotypes for the development of TCR-T cell therapies against ALK-positive cancers. Cancer Research. 84(6_Supplement). 21–21. 1 indexed citations

2.

Cauda, Valentina, Elisabetta Mereu, Elisa Bergaggio, et al.. (2021). Biomimetic mesoporous vectors enabling the efficient inhibition of wild-type isocitrate dehydrogenase in multiple myeloma cells. Microporous and Mesoporous Materials. 325. 111320–111320. 9 indexed citations

3.

Bergaggio, Elisa & Roberto Piva. (2019). Wild-Type IDH Enzymes as Actionable Targets for Cancer Therapy. Cancers. 11(4). 563–563. 39 indexed citations

4.

Bergaggio, Elisa, Chiara Riganti, Giulia Garaffo, et al.. (2018). IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies. Blood. 133(2). 156–167. 47 indexed citations

5.

Osella‐Abate, Simona, Elisabetta Mereu, Elisa Pellegrino, et al.. (2018). ALK expression favorably impacts the prognosis of NRAS‑mutated metastatic melanomas. Oncology Letters. 16(6). 7091–7096. 2 indexed citations

6.

Agnelli, Luca, Elisabetta Mereu, Elisa Pellegrino, et al.. (2012). Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma. Blood. 120(6). 1274–1281. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact